Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

DeVEnIR: Defining Vulvovaginal Candidiasis - Elements of Infection and Remedy

NCT06397248 is registered in ClinicalTrials.gov with University Hospital, Antwerp as lead sponsor.

NCT NCT06397248
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06397248 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
DeVEnIR: Defining Vulvovaginal Candidiasis - Elements of Infection and Remedy
Lead sponsor
University Hospital, Antwerp
Phase
Observational
Overall status
Active, not recruiting
Start date
May 22, 2024
Completion date
September 30, 2027
Enrollment
300 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

vulvovaginal candidiasis